Literature DB >> 15181269

Evolution of HLA antibody detection: technology emulating biology.

Robert A Bray1, Peter W Nickerson, Ronald H Kerman, Howard M Gebel.   

Abstract

New technological advances in the field of histocompatibility have provided an approach to systematically address the specificity of positive lymphocyte crossmatches. These approaches can now confirm whether a positive crossmatch is (or is not) due to class I and/or class II antibodies directed against donor HLA antigens. The information gained from the application of these sensitive and specific technologies can be used to predict crossmatch results for highly sensitized patients. In summary, these emerging technologies have provided the tools to reliably determine the clinical relevance of a positive lymphocyte crossmatch.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15181269     DOI： 10.1385/IR:29:1-3:041

Source DB:  PubMed          Journal:  Immunol Res        ISSN： 0257-277X            Impact factor:   2.829


  34 in total

1.  Simultaneous HLA Class I and Class II antibodies screening with flow cytometry.

Authors:  R Pei; G Wang; C Tarsitani; S Rojo; T Chen; S Takemura; A Liu; J Lee
Journal:  Hum Immunol       Date:  1998-05       Impact factor: 2.850

Review 2.  Alloantigen processing and presentation.

Authors:  A R Tambur; H M Gebel
Journal:  J Heart Lung Transplant       Date:  1995 Nov-Dec       Impact factor: 10.247

3.  Improved flow cytometric detection of HLA alloantibodies using pronase: potential implications in renal transplantation.

Authors:  S Vaidya; T Y Cooper; J Avandsalehi; T Barnes; K Brooks; P Hymel; M Noor; R Sellers; A Thomas; D Stewart; J Daller; J C Fish; K K Gugliuzza; R A Bray
Journal:  Transplantation       Date:  2001-02-15       Impact factor: 4.939

4.  Clinical and economic impact of flow cytometry crossmatching in primary cadaveric kidney and simultaneous pancreas-kidney transplant recipients.

Authors:  R P Pelletier; C G Orosz; P W Adams; G L Bumgardner; E A Davies; E A Elkhammas; M L Henry; R M Ferguson
Journal:  Transplantation       Date:  1997-06-15       Impact factor: 4.939

5.  Detection of alloantibodies using a sensitive antiglobulin microcytotoxicity test: identification of low levels of pre-formed antibodies in accelerated allograft rejection.

Authors:  A H Johnson; R D Rossen; W T Butler
Journal:  Tissue Antigens       Date:  1972

6.  Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells.

Authors:  F Kissmeyer-Nielsen; S Olsen; V P Petersen; O Fjeldborg
Journal:  Lancet       Date:  1966-09-24       Impact factor: 79.321

7.  "Hyperacute" renal-homograft rejection in man.

Authors:  G M Williams; D M Hume; R P Hudson; P J Morris; K Kano; F Milgrom
Journal:  N Engl J Med       Date:  1968-09-19       Impact factor: 91.245

8.  The flow cytometric crossmatch and early renal transplant loss.

Authors:  R J Mahoney; K A Ault; S R Given; R J Adams; A C Breggia; P A Paris; G E Palomaki; S A Hitchcox; B W White; J Himmelfarb
Journal:  Transplantation       Date:  1990-03       Impact factor: 4.939

9.  HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm.

Authors:  René J Duquesnoy
Journal:  Hum Immunol       Date:  2002-05       Impact factor: 2.850

10.  Antigenic specificity of antibody reactive in the antiglobulin-augmented lymphocytotoxicity test.

Authors:  T C Fuller; D Phelan; H M Gebel; G E Rodey
Journal:  Transplantation       Date:  1982-07       Impact factor: 4.939
View more
  12 in total

1.  Re-Examining Risk of Repeated HLA Mismatch in Kidney Transplantation.

Authors:  Kathryn J Tinckam; Caren Rose; Sundaram Hariharan; John Gill
Journal:  J Am Soc Nephrol       Date:  2016-02-17       Impact factor: 10.121

Review 2.  HLA antibody analysis: sensitivity, specificity, and clinical significance in solid organ transplantation.

Authors:  Adriana Zeevi; Alin Girnita; Rene Duquesnoy
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

3.  Approach to the Highly Sensitized Kidney Transplant Candidate.

Authors:  Douglas S Keith; Gayle M Vranic
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-25       Impact factor: 8.237

4.  Perception versus reality?: Virtual crossmatch--how to overcome some of the technical and logistic limitations.

Authors:  A R Tambur; D S Ramon; D B Kaufman; J Friedewald; X Luo; B Ho; A Skaro; J Caicedo; D Ladner; T Baker; J Fryer; L Gallon; J Miller; M M Abecassis; J Leventhal
Journal:  Am J Transplant       Date:  2009-06-26       Impact factor: 8.086

Review 5.  Utility of HLA Antibody Testing in Kidney Transplantation.

Authors:  Ana Konvalinka; Kathryn Tinckam
Journal:  J Am Soc Nephrol       Date:  2015-03-24       Impact factor: 10.121

6.  The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure.

Authors:  Stephen Spellman; Robert Bray; Sandra Rosen-Bronson; Michael Haagenson; John Klein; Susan Flesch; Cynthia Vierra-Green; Claudio Anasetti
Journal:  Blood       Date:  2010-01-20       Impact factor: 22.113

7.  Virtual HLA Crossmatching as a Means to Safely Expedite Transplantation of Imported Pancreata.

Authors:  Brian C Eby; Robert R Redfield; Thomas M Ellis; Glen E Leverson; Abby R Schenian; Jon S Odorico
Journal:  Transplantation       Date:  2016-05       Impact factor: 4.939

8.  Addition of plasmapheresis decreases the incidence of acute antibody-mediated rejection in sensitized patients with strong donor-specific antibodies.

Authors:  Enver Akalin; Rajani Dinavahi; Rex Friedlander; Scott Ames; Graciela de Boccardo; Vinita Sehgal; Bernd Schröppel; Madhu Bhaskaran; Susan Lerner; Marileno Fotino; Barbara Murphy; Jonathan S Bromberg
Journal:  Clin J Am Soc Nephrol       Date:  2008-03-12       Impact factor: 8.237

9.  Measuring alloreactive B cell responses in transplant recipients.

Authors:  Suheyla Hasgur; Anna Valujskikh
Journal:  Curr Transplant Rep       Date:  2019-01-24

Review 10.  Advances in diagnosing and managing antibody-mediated rejection.

Authors:  Stanley C Jordan; Nancy Reinsmoen; Alice Peng; Chih-Hung Lai; Kai Cao; Rafael Villicana; Mieko Toyoda; Joseph Kahwaji; Ashley A Vo
Journal:  Pediatr Nephrol       Date:  2010-01-14       Impact factor: 3.714
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.